Boerboom L E, Olinger G N, Liu T Z, Rodriguez E R, Ferrans V J, Kissebah A H
Department of Cardiothoracic Surgery, Medical College of Wisconsin, Milwaukee.
J Thorac Cardiovasc Surg. 1990 Jan;99(1):107-12.
The objective of this study was to determine the early influence of platelet inhibition on the histologic, morphometric, and biochemical evolution of vein bypass grafts in a nonhuman primate model. Cephalic vein grafts were interposed bilaterally in the femoral arteries of 15 stump-tailed macaque monkeys fed a diet that sustains plasma cholesterol levels of approximately 225 mg/dl. All animals received in combination aspirin, 80 mg/day, and dipyridamole, 50 mg/day. Grafts were excised from five animals for analysis on each of postoperative days 3, 7, 14, 30, 60, and 90. In animals subjected to platelet inhibition, cholesterol content in the graft was 170 +/- 52 micrograms/100 mg at 90 days, 205% of the level in ungrafted vein (p less than 0.01). This change was small in comparison with the increase to 686% of ungrafted vein observed in our study of control animals. In stepwise regression analysis, cholesterol content of grafts was best predicted by prevalence of foam cells (r2 = 0.82), and the proportion of intima as a fraction of total wall area was best predicted by the presence of macrophages (r2 = 0.69). Platelet inhibition did not decrease the extent of intimal hyperplasia. The prevalence of adherent platelets (r = -0.72) and the amount of fibrin (r = -0.78) correlated inversely with the amount of endothelium present during the first 14 days. The strength of these correlations declined with time, despite persistent lack of endothelium in some areas. Medial fibrosis occurred to the same extent as in control grafts, as did the early appearance of platelet factor VIII and fibronectin and the lack of vasa vasorum at 3 days followed by reappearance at 7 days. These data demonstrate that platelet inhibition dramatically reduces lipid uptake by grafts in the first 90 days but has less influence over histologic or morphometric changes.
本研究的目的是在非人类灵长类动物模型中确定血小板抑制对静脉搭桥移植物组织学、形态学和生化演变的早期影响。将头静脉移植物双侧植入15只断尾猕猴的股动脉中,这些猕猴的饮食维持血浆胆固醇水平约为225mg/dl。所有动物均联合接受阿司匹林80mg/天和双嘧达莫50mg/天治疗。在术后第3、7、14、30、60和90天,分别从5只动物身上取出移植物进行分析。在接受血小板抑制的动物中,90天时移植物中的胆固醇含量为170±52微克/100毫克,是未移植静脉中胆固醇水平的205%(p<0.01)。与我们在对照动物研究中观察到的未移植静脉中胆固醇水平增加至686%相比,这种变化较小。在逐步回归分析中,移植物中胆固醇含量最好由泡沫细胞的患病率预测(r2 = 0.82),内膜占总壁面积的比例最好由巨噬细胞的存在预测(r2 = 0.69)。血小板抑制并未降低内膜增生的程度。在最初的14天内,黏附血小板的患病率(r = -0.72)和纤维蛋白的量(r = -0.78)与内皮细胞的量呈负相关。尽管某些区域持续缺乏内皮细胞,但这些相关性的强度随时间下降。中层纤维化的程度与对照移植物相同,血小板因子VIII和纤连蛋白的早期出现以及术后3天无血管滋养管、7天再次出现的情况也与对照移植物相同。这些数据表明,血小板抑制在最初90天内可显著降低移植物对脂质的摄取,但对组织学或形态学变化的影响较小。